OakChart

Community Health Systems Inc

CYHHealthcare·Medical Care Facilities·USA·Small·NYSE·Nov 11 • 3:59 PM ET

2.29+0.12 (5.53%)
2026-11-12 03:43 CET
Market cap
322.95 USD m
Revenue, TTM
11,653.00 USD m
Net income, TTM
36.00 USD m
Free cash flow, TTM
-122.00 USD m
EPS diluted, TTM
0.25
P/E
9.17
Compare

Price

CYH against its 20, 50 and 200-day averages
2050200beatmiss
2.002.503.003.504.004.0M8.0MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26CYHclose 2.2920-day 2.5650-day 2.75200-day 2.992.2952w high52w low

41.6% under the 52-week high of 3.92 on 2 Jul 2026. 52-week low 2.04 on 3 Nov 2026. Last 15 sessions, 48.4% high to low

Volume 3.56× normal · the line is the 50-bar volume average

Profile

CYH
52-week range, 13% of the way up
2.043.92

Community Health Systems, Inc. engages in the provision of general and specialized healthcare services and outpatient services. The company was founded in March 1985 and is headquartered in Franklin, TN.

IndexRUT
Employees57000
IPOJun 09, 2000
Beta1.91
ATR, 14d0.17
Rel volume3.56
Short float11.47%
Insider own22.08%
Inst own73.63%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap322.95M
Enterprise Value10.93B
Income36.00M
Sales11.65B
Book/sh-10.58
Cash/sh1.10
Dividend Est.-
Dividend TTM-
Dividend Ex-DateDec 13, 2012
Dividend Gr. 3/5Y- -
Payout0.00%
Employees57000
IPOJun 09, 2000

Ratios

P/E9.17
Forward P/E-
PEG-
P/S0.03
P/B-
P/C2.08
P/FCF-
EV/EBITDA8.47
EV/Sales0.94
Quick Ratio1.35
Current Ratio1.48
Debt/Eq-
LT Debt/Eq-
Option/ShortYes / Yes

Earnings

EPS (ttm)0.25
EPS next Y-0.93
EPS next Q-0.29
EPS this Y-208.93%
EPS next Y27.92%
EPS next 5Y-
EPS past 3/5Y120.07% -2.98%
Sales past 3/5Y0.74% 1.15%
EPS Y/Y TTM-88.93%
Sales Y/Y TTM-7.84%
EPS Q/Q-165.98%
Sales Q/Q-10.69%
EarningsOct 28 AMC
EPS/Sales Surpr.-63.54% -1.58%

Ownership

Insider Own22.08%
Insider Trans-0.13%
Inst Own73.63%
Inst Trans7.95%
ROA0.28%
ROE-
ROIC0.42%
Gross Margin7.33%
Oper. Margin7.33%
Profit Margin0.31%
SMA20-10.41%
SMA50-16.78%
SMA200-23.45%
Trades-

Technical

Shs Outstand141.00M
Shs Float109.89M
Short Float11.47%
Short Ratio8.86
Short Interest12.61M
52W High3.92 -41.58%
52W Low2.04 12.53%
Volatility7.72% 6.64%
ATR (14)0.17
RSI (14)40.21
Beta1.91
Rel Volume3.56
Avg Volume1.42M
Volume5,069,380

Performance

Perf Week-3.78%
Perf Month-23.41%
Perf Quarter-22.90%
Perf Half Y-21.31%
Perf YTD-26.60%
Perf Year-33.82%
Perf 3Y-2.97%
Perf 5Y-84.67%
Perf 10Y-52.98%
Recom3.20
Target Price2.63
Prev Close2.17
Price2.29
Change %5.53%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Sep 23, 2026InitiatedBBMO Capital MarketsMarket Perform$3+31.0%
Jul 08, 2026DowngradeBBarclaysEqual Weight → Underweight$3+31.0%
Jul 24, 2025DowngradeJJefferiesBuy → Hold$3+31.0%
Nov 25, 2024DowngradeWWells FargoEqual Weight → Underweight$5 → $2.50+9.2%
Nov 22, 2024DowngradeRRaymond JamesMkt Perform → Underperform
Mar 06, 2024InitiatedBBarclaysEqual Weight$3+31.0%
Jun 17, 2022InitiatedLLoop CapitalHold$5+118.3%
Jun 15, 2022DowngradeBBofA SecuritiesBuy → Neutral$7.50 → $5.50+140.2%
Mar 29, 2022InitiatedWWells FargoEqual Weight$12+424.0%
Jan 10, 2022ResumedCCitigroupBuy$16 → $18+686.0%

Peers

Mkt cap
TickerCompanyMkt cap
THCTenet Healthcare Corp23.32B
ARDTArdent Health Inc2.56B
HCAHCA Healthcare Inc105.71B
UHSUniversal Health Services Inc11.34B
NUTXNutex Health Inc1.30B
SGRYSurgery Partners Inc3.49B
ACHCAcadia Healthcare Company Inc3.61B
AUNAAuna SA347.12M
EHCEncompass Health Corp13.96B
MDPediatrix Medical Group Inc2.46B

Insider trading

latest 14 of 17
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
JENNINGS WILLIAM NORRISDirectorAug 25 '26Sale2.9640,000118,40038,468Aug 25 05:23 PM
William Norris JenningsDirectorAug 25 '26Proposed Sale3.0040,000120,000Aug 25 12:10 PM
Krishnan K RangaDirectorJun 30 '26Option Exercise0.0013,9300170,023Jun 30 04:56 PM
Krishnan K RangaDirectorApr 22 '26Option Exercise0.0046,9500156,093Apr 22 04:47 PM
STOCKTON KEVIN AEVP, Operations & DevelopmentMar 01 '26Option Exercise0.0050,0000213,863Mar 03 04:47 PM
Pitt Justin DPres,Chief Legal&Admin OfficerMar 01 '26Option Exercise0.0030,0000272,672Mar 03 04:46 PM
Johnson Jason KEVP & CFOMar 01 '26Option Exercise0.0030,0000202,049Mar 03 04:45 PM
HAMMONS KEVIN JCEOMar 01 '26Option Exercise0.00156,2400792,441Mar 03 04:45 PM
Williams Hubert JamesDirectorMar 01 '26Option Exercise0.0050,5950211,863Mar 03 04:44 PM
Hirsch Elizabeth TDirectorMar 01 '26Option Exercise0.0050,5950162,059Mar 03 04:38 PM
FRY JOHN ADirectorMar 01 '26Option Exercise0.0050,5950268,966Mar 03 04:36 PM
Ely James S. IIIDirectorMar 01 '26Option Exercise0.0050,5950412,876Mar 03 04:36 PM
DINKINS MICHAELDirectorMar 01 '26Option Exercise0.0030,6620225,882Mar 03 04:34 PM
CLERICO JOHN ADirectorMar 01 '26Option Exercise0.0050,5950368,763Mar 03 04:33 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWNiShares Russell 2000 Value ETFAUM: 14.10B
VTWOVanguard Russell 2000 Index ETFAUM: 16.75B
DFASU.S. Small Cap Portfolio-ETF Class SharesAUM: 15.51B
FNDXSchwab Fundamental U.S. Large Company ETFAUM: 28.61B
SCHASchwab U.S. Small-Cap ETFAUM: 22.25B
DFMCU.S. Micro Cap Portfolio ETF Class SharesAUM: 212.10M
VHTVanguard Health Care ETFAUM: 21.51B

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-10-28-0.480-0.294-0.6302,7572,8016
2026Q22026-07-22-0.190-0.1040.5132,8252,8857
2026Q12026-04-21-0.480-0.114-0.4322,9652,9518
2025Q42026-02-18-0.010-0.0510.8033,1063,1378
2025Q32025-10-231.270-0.2480.9623,0872,9938
2025Q22025-07-23-0.050-0.1052.0913,1333,0487
2025Q12025-04-23-0.030-0.079-0.0983,1593,0979
2024Q42025-02-18-0.4200.082-0.5303,2653,1497
2024Q32024-10-23-0.300-0.212-2.9543,0903,0798
2024Q22024-07-24-0.170-0.136-0.0983,1403,0969
2024Q12024-04-24-0.140-0.162-0.3123,1403,0938
2023Q42024-02-20-0.4100.0520.3493,1813,1558
2023Q32023-10-25-0.330-0.156-0.6963,0863,0378
2023Q22023-08-02-0.220-0.261-0.2913,1153,03510
2023Q12023-05-01-0.430-0.183-0.3933,1083,0678
2022Q42023-02-151.5000.3473.1853,1423,1559

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2017FY-1.200-1.294-22.00115,35315,830
2018FY-1.940-2.033-6.99014,15514,082
2019FY-0.890-1.751-5.93513,21013,106
2020FY0.450-0.3454.38511,78911,742
2021FY2.4501.7301.76112,36812,299
2022FY-1.380-2.6860.35412,21112,234
2023FY-1.390-0.853-1.02012,49012,469
2024FY-1.030-0.517-3.90612,63412,529
2025FY1.1900.8613.77012,48512,492
2026FY--1.296--11,362
2027FY--0.934--11,332
2028FY--0.950--11,618

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-10-308042,8132,7592,877
2026Q4S2026-10-298032,8292,7592,877
2026Q4S2026-10-288002,8602,8452,877
2026Q4S2026-10-138002,8602,8452,877
2026Q4S2026-10-108012,8602,8452,877
2026Q4S2026-10-078022,8602,8452,877
2026Q4S2026-10-068032,8602,8452,877
2026Q4S2026-09-218152,8602,8452,877
2026Q4S2026-07-307152,8612,8452,877
2026Q4S2026-07-277142,8662,8522,879
2026Q4S2026-07-247132,8732,8522,913
2026Q4S2026-07-237122,8792,8522,920
2026Q4S2026-07-087002,9032,8272,942
2026Q4S2026-07-077102,9032,8272,942

Estimate history

EPS, annual-22.001-6.99-5.9354.3851.7610.354-1.02-3.9063.770.2497
Period201720182019202020212022202320242025TTM
EPS, quarterly-2.954-0.53-0.0982.0910.9620.803-0.4320.513-0.635
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual15353141551321011789123681221112490126341248511653
Period201720182019202020212022202320242025TTM
Sales, quarterly309032653159313330873106296528252757
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual114.651116.248117.823129.612132.146134.704136.775138.92138.627140.999
Period201720182019202020212022202320242025MRQ
Shares, quarterly138.936138.92140.303140.12140.12138.627140.917141.01140.999
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue11,653.0012,485.0012,634.0012,490.0012,211.0012,368.0011,789.0013,210.0014,155.00
Cost of Goods Sold Incl. D&A10,799.0011,403.0011,791.0011,582.0011,483.0011,086.0011,212.0012,307.0013,269.00
Gross Profit854.001,082.00843.00908.00728.001,282.00577.00903.00886.00
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income854.001,082.00843.00908.00728.001,282.00577.00903.00886.00
Interest Expense842.00872.00863.00832.00860.00888.001,036.001,047.00985.00
Unusual Expense21.00-97.00-25.00-34.00-346.00-41.00-866.00308.00651.00
Net Income Before Taxes412.00724.00-283.00207.00349.00499.00422.00-430.00-715.00
Income Taxes223.0048.0079.00191.00170.00131.00-185.00160.00-11.00
Consolidated Net Income189.00676.00-362.0016.00179.00368.00607.00-590.00-704.00
Net Income From Continuing Operations36.00509.00-516.00-133.0046.00230.00511.00-675.00-788.00
Net Income36.00509.00-516.00-133.0046.00230.00511.00-675.00-788.00
EPS (Recurring)0.373.27-4.04-1.20-1.511.54-0.82-4.04-2.95
EPS (Basic, Before Extraordinaries)0.273.81-3.91-1.020.361.814.42-5.93-6.99
EPS (Diluted)0.253.77-3.91-1.020.351.764.38-5.93-6.99
EBITDA1,290.001,508.001,329.001,413.001,262.001,822.001,135.001,511.001,586.00
Non-Operating Income (Expense)421.00417.00-288.0097.00135.0064.0015.0022.0035.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense9.328.0013.0017.0015.8018.259.497.3010.27
Price To Earnings Ratio9.179.17-1.73-7.721.73--
Price To Sales Ratio0.030.030.030.030.050.140.070.020.02
Gross Margin7.338.676.677.275.9610.374.896.846.26
Operating Margin7.338.676.677.275.9610.374.896.846.26
Net Margin0.314.08-4.08-1.060.381.864.33-5.11-5.57
Shares Outstanding141.00138.63138.92136.77134.70132.15129.61117.82116.25
Market Capitalization322.95322.95415.45428.19581.961,758.36888.78341.75327.92

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue2,757.002,825.002,965.003,106.003,087.003,133.003,159.003,265.00
Cost of Goods Sold Incl. D&A2,597.002,608.002,774.002,820.002,823.002,860.002,899.002,979.00
Gross Profit160.00217.00191.00286.00264.00273.00260.00286.00
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income160.00217.00191.00286.00264.00273.00260.00286.00
Interest Expense201.00206.00213.00222.00216.00214.00219.00218.00
Unusual Expense0.005.008.008.0033.00-138.000.000.00
Net Income Before Taxes-53.00180.0064.00221.00-2.00438.0067.0064.00
Income Taxes-3.0076.0089.0061.00-173.00118.0042.0092.00
Consolidated Net Income-50.00104.00-25.00160.00171.00320.0025.00-28.00
Net Income From Continuing Operations-86.0070.00-58.00110.00130.00282.00-13.00-70.00
Net Income-86.0070.00-58.00110.00130.00282.00-13.00-70.00
EPS (Recurring)-0.630.54-0.390.841.131.37-0.10-0.53
EPS (Basic, Before Extraordinaries)-0.630.52-0.430.820.972.11-0.10-0.53
EPS (Diluted)-0.630.51-0.430.800.962.09-0.10-0.53
EBITDA266.00325.00305.00394.00372.00378.00365.00415.00
Non-Operating Income (Expense)-12.00174.0094.00165.00-17.00241.0026.00-4.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense2.371.582.373.00-0.792.373.163.00
Price To Earnings Ratio9.170.980.781.29----
Price To Sales Ratio0.030.040.030.030.030.040.030.03
Gross Margin5.807.686.449.218.558.718.238.76
Operating Margin5.807.686.449.218.558.718.238.76
Net Margin-3.122.48-1.963.544.219.00-0.41-2.14
Shares Outstanding141.00141.01140.92138.63140.12140.12140.30138.92
Market Capitalization322.95470.66407.56432.18449.78477.04379.06415.45

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments260.0037.0038.00118.00507.001,676.00216.00196.00563.00
Short Term Receivables2,231.002,447.002,361.002,137.002,176.002,063.002,395.002,507.002,537.00
Inventories322.00331.00328.00353.00355.00335.00354.00402.00444.00
Other Current Assets421.00486.00481.00474.00441.00436.00462.00444.00524.00
Total Current Assets3,234.003,301.003,208.003,082.003,479.004,510.003,427.003,549.004,068.00
Net Property, Plant & Equipment5,120.005,399.005,872.006,103.006,221.005,964.006,215.006,139.007,052.00
Total Investments and Advances138.00152.00170.00155.00129.00190.00283.00269.00171.00
Intangible Assets3,460.003,961.004,163.004,390.004,489.004,524.004,713.004,982.005,228.00
Deferred Tax Assets676.0013.0029.0049.0053.0059.0038.0069.0062.00
Other Assets1,202.001,228.001,013.00890.00846.00759.00933.00851.00869.00
Total Assets13,830.0014,054.0014,455.0014,669.0015,217.0016,006.0015,609.0015,859.0017,450.00
Short Term Debt Incl. Current Port. of LT Debt126.00135.00145.00169.00178.00265.00156.00204.0033.00
Accounts Payable733.00784.00811.00686.00725.00683.00718.00772.00801.00
Other Current Liabilities1,349.001,426.001,186.001,331.001,461.001,867.001,408.001,416.001,522.00
Total Current Liabilities2,208.002,345.002,142.002,186.002,364.002,815.002,282.002,392.002,356.00
Long Term Debt10,917.0011,967.0012,029.0012,219.0012,644.0012,617.0013,872.0013,392.0013,880.00
Provision for Risks Charges481.00428.00368.00401.00470.00519.00527.00627.00691.00
Deferred Tax Liabilities651.00231.00369.00354.00192.0029.00200.0026.0019.00
Other Liabilities410.00400.00371.00243.00357.001,080.00367.00381.00669.00
Total Liabilities14,667.0015,371.0015,279.0015,403.0016,027.0017,060.0017,248.0016,818.0017,615.00
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity-1,394.00-1,914.00-1,392.00-1,367.00-1,372.00-1,625.00-2,218.00-1,535.00-767.00
Total Shareholders Equity-1,394.00-1,914.00-1,392.00-1,367.00-1,372.00-1,625.00-2,218.00-1,535.00-767.00
Accumulated Minority Interest557.00597.00568.00633.00562.00571.00579.00576.00602.00
Total Equity-837.00-1,317.00-824.00-734.00-810.00-1,054.00-1,639.00-959.00-165.00
Total Liabilities & Stockholders Equity13,830.0014,054.0014,455.0014,669.0015,217.0016,006.0015,609.0015,859.0017,450.00
Book Value Per Share-10.06-13.78-10.18-10.15-10.38-12.54-18.82-13.20-6.69
Tangible Book Value Per Share-35.01-42.29-40.61-42.74-44.35-47.44-58.83-56.06-52.29
Full-Time Employees57,00060,00061,00066,00066,00070,00080,00087,00095,000
Price to Book Ratio-0.22-0.23-0.29-0.33-1.28-0.59-0.15-0.210.40
Return on Assets3.65-3.62-0.910.311.473.23-4.29-4.73-12.42
Return on Equity---------577.12
Return on Invested Capital5.34-5.13-1.250.422.044.65-5.79-6.65-18.75
Quick Ratio1.321.271.341.251.321.481.351.321.54
Current Ratio1.461.411.501.411.471.601.501.481.73

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income188.00676.00-362.0016.00179.00368.00607.00-590.00-704.00
Depreciation437.00426.00486.00505.00534.00540.00558.00608.00700.00
Other Funds (Non Cash)-224.00-319.00481.0044.00-99.00167.00-125.00435.00699.00
Funds from Operations433.00540.00489.00600.00779.001,245.00853.00656.00692.00
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-222.003.00-9.00-390.00-479.00-1,376.001,325.00-271.00-418.00
Cash from Operating Activities211.00543.00480.00210.00300.00-131.002,178.00385.00274.00
Capital Expenditures-333.00-335.00-360.00-467.00-415.00-469.00-440.00-438.00-527.00
Net Assets From Acquisitions-55.00-4.00-28.00-39.00-14.00-22.00-2.00-24.00-57.00
Sale of Fixed Assets and Businesses1,453.001,264.00180.00465.00140.0027.00667.00617.00416.00
Purchase or Sale of Investments-29.00-79.00-69.0019.00-83.00-79.00-34.00-158.00-105.00
Purchase of Investments-145.00-202.00-149.00-213.00-193.00-291.00-228.00-250.00-219.00
Sale Or Maturity of Investments116.00123.0080.00232.00110.00212.00194.0092.00114.00
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.00121.000.000.000.000.00
Cash from Investing Activities1,036.00846.00-277.00-22.00-251.00-543.00191.00-3.00-273.00
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock-2.00-2.00-1.00-4.00-8.00-5.00-1.00-1.00-1.00
Repurchase of Common Pref Stock-2.00-2.00-1.00-4.00-8.00-5.00-1.00-1.00-1.00
Sale of Common Pref Stock0.000.000.000.000.000.000.000.000.00
Proceedsfrom Stock Options0.000.000.000.000.000.000.000.000.00
Issuance or Reduction of Debt, Net-1,040.00-1,000.00-48.00-123.00-305.00-369.00-794.00-322.00-1,068.00
Change in Long Term Debt-1,040.00-1,000.00-48.00-123.00-305.00-369.00-794.00-322.00-1,068.00
Issuance of Long Term Debt1,355.005,516.005,015.004,201.002,051.004,057.004,699.003,235.00965.00
Reduction of Long Term Debt-2,395.00-6,516.00-5,063.00-4,324.00-2,356.00-4,426.00-5,493.00-3,557.00-2,033.00
Net Financing Active Other Cash Flow-173.00-164.00-155.00-141.00-125.00-121.00-114.00-39.00701.00
Other Financing Activities Uses-173.00-164.00-155.00-141.00-125.00-121.00-116.00-99.00-96.00
Cash from Financing Activities-1,215.00-1,166.00-204.00-268.00-438.00-495.00-909.00-362.00-368.00
Net Change in Cash32.00223.00-1.00-80.00-389.00-1,169.001,460.0020.00-367.00
Free Cash Flow-122.00208.00120.00-257.00-115.00-600.001,738.00-53.00-253.00
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow-2.033.29---0.50--
Deferred Taxes & Investment Tax Credit--243.00-116.0035.00165.00170.00-187.00203.00-3.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments155.00149.00712.00260.00123.00456.00
Short Term Receivables2,209.002,270.002,332.002,231.002,277.002,389.00
Inventories268.00271.00275.00322.00325.00326.00
Other Current Assets367.00391.00454.00421.00473.00488.00
Total Current Assets2,999.003,081.003,773.003,234.003,198.003,659.00
Net Property, Plant & Equipment4,822.004,774.004,770.005,120.005,228.005,256.00
Total Investments and Advances0.000.000.00138.000.000.00
Intangible Assets3,233.003,228.003,130.003,460.003,540.003,604.00
Deferred Tax Assets36.0035.0029.00676.0075.0013.00
Other Assets1,018.001,059.001,478.001,202.001,198.001,109.00
Total Assets12,108.0012,177.0013,180.0013,830.0013,239.0013,641.00
Short Term Debt Incl. Current Port. of LT Debt118.00126.00126.00126.00126.00135.00
Accounts Payable831.00713.00790.00733.00894.00970.00
Income Tax Payable55.0074.0053.00-3.00-
Other Current Liabilities1,017.001,103.001,598.001,349.001,155.001,190.00
Total Current Liabilities2,021.002,016.002,567.002,208.002,178.002,295.00
Long Term Debt10,091.0010,079.0010,631.0010,917.0011,116.0011,354.00
Provision for Risks Charges0.000.000.00481.000.000.00
Deferred Tax Liabilities25.0025.0025.00651.0030.00240.00
Other Liabilities908.00901.00922.00410.00866.00850.00
Total Liabilities13,045.0013,021.0014,145.0014,667.0014,190.0014,739.00
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity-1,492.00-1,390.00-1,454.00-1,394.00-1,502.00-1,631.00
Total Shareholders Equity-1,492.00-1,390.00-1,454.00-1,394.00-1,502.00-1,631.00
Accumulated Minority Interest555.00546.00489.00557.00551.00533.00
Total Equity-937.00-844.00-965.00-837.00-951.00-1,098.00
Total Liabilities & Stockholders Equity12,108.0012,177.0013,180.0013,830.0013,239.0013,641.00
Book Value Per Share-10.58-9.86-10.32-10.06-10.72-11.64
Tangible Book Value Per Share-33.51-32.75-32.53-35.01-35.98-37.36
Full-Time Employees---57,000--
Price to Book Ratio-0.22-0.32-0.29-0.29-0.28-0.25
Return on Assets0.281.953.433.652.42-1.37
Return on Invested Capital-1.000.81-0.631.161.352.90
Quick Ratio1.351.391.361.321.321.45
Current Ratio1.481.531.471.461.471.59

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-51.00104.00-25.00160.00171.00320.00
Depreciation106.00108.00114.00109.00106.00106.00
Other Funds (Non Cash)54.00-126.00-39.00-113.0096.00-327.00
Funds from Operations123.0086.0050.00174.00103.00134.00
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital31.002.00-347.0092.00-34.00-46.00
Cash from Operating Activities154.0088.00-297.00266.0069.0088.00
Capital Expenditures-87.00-76.00-76.00-94.00-65.00-91.00
Net Assets From Acquisitions-1.00-48.00-5.00-1.00-3.000.00
Sale of Fixed Assets and Businesses-7.00110.001,108.00242.003.00456.00
Purchase or Sale of Investments-10.00-9.00-4.00-6.00-17.00-22.00
Purchase of Investments-27.00-27.00-49.00-42.00-46.00-57.00
Sale Or Maturity of Investments17.0018.0045.0036.0029.0035.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-105.00-23.001,023.00141.00-82.00343.00
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.000.00-2.000.000.00-1.00
Repurchase of Common Pref Stock0.000.00-2.000.000.00-1.00
Sale of Common Pref Stock0.000.000.000.000.000.00
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net-4.00-595.00-215.00-226.00-296.00-344.00
Change in Long Term Debt-4.00-595.00-215.00-226.00-296.00-344.00
Issuance of Long Term Debt603.00598.00136.0018.002,596.001,948.00
Reduction of Long Term Debt-607.00-1,193.00-351.00-244.00-2,892.00-2,292.00
Net Financing Active Other Cash Flow-39.00-33.00-57.00-44.00-24.00-61.00
Other Financing Activities Uses-39.00-33.00-57.00-44.00-24.00-61.00
Cash from Financing Activities-43.00-628.00-274.00-270.00-320.00-406.00
Net Change in Cash6.00-563.00452.00137.00-333.0025.00
Free Cash Flow67.0012.00-373.00172.004.00-3.00
Price to Free Cash Flow---2.063.033.37

Revenue breakdown

Managed Care And Other Third Party Payors2024: 6.08B 2025: 5.98B
Medicaid2024: 1.87B 2025: 1.99B
Medicare2024: 2.28B 2025: 2.17B
Medicare Managed Care2024: 2.24B 2025: 2.25B
Self Pay2024: 162.00M 2025: 96.00M
United States2024: 12.63B 2025: 12.49B

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3011.47%12.6M109.9M1.30M
2026-10-1511.19%12.3M109.9M1.40M
2026-09-3011.25%12.4M109.9M1.58M
2026-09-1512.35%13.5M109.7M1.63M
2026-08-3112.00%13.2M109.7M1.68M
2026-08-1412.05%13.2M109.7M1.73M
2026-07-3112.21%13.4M110.0M1.77M
2026-07-1510.98%12.1M109.9M1.80M
2026-06-3011.07%12.2M109.9M1.61M
2026-06-1511.25%12.4M109.9M1.62M
2026-05-2911.67%12.8M109.9M1.62M
2026-05-1511.12%12.2M110.0M1.69M
2026-04-3010.03%11.7M116.6M1.81M
2026-04-159.56%11.2M116.7M1.64M
2026-03-319.88%11.3M114.7M1.66M
2026-03-139.37%10.8M114.7M1.57M
2026-02-278.75%10.0M114.7M1.71M
2026-02-138.95%10.3M114.7M1.69M
2026-01-308.85%10.0M113.3M1.63M
2026-01-158.17%9.3M113.3M1.99M

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call0.501.302.050.0014.3090.000.000.971-0.0100.000
call1.000.701.702.1510.3560.000.000.943-0.0100.000
call1.500.301.050.004.9460.000.000.901-0.0090.001
call2.000.000.750.354.4953.000.000.805-0.0070.001
call3.000.000.250.123.2581610.000.394-0.0250.001
call4.000.000.600.004.4930.000.000.330-0.0330.001
call5.000.000.600.005.3240.000.000.301-0.0380.001
call6.000.000.050.003.8540.000.000.098-0.0120.001
put0.500.000.600.007.5130.000.00-0.029-0.0100.000
put1.000.000.600.004.3070.000.00-0.057-0.0100.000
put1.500.000.600.002.5200.000.00-0.099-0.0090.001
put2.000.000.650.181.1803.000.00-0.195-0.0070.001
put3.000.451.300.805.75043.000.00-0.606-0.0250.001
put4.001.402.250.006.6850.000.00-0.670-0.0330.001
put5.002.303.300.007.9130.000.00-0.699-0.0370.001
put6.003.404.400.009.2780.000.00-0.903-0.0130.001

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-108-KCurrent report2026-11-09SEC
2026-10-2910-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-10-288-KCurrent report2026-10-28SEC
2026-08-25144Filing for proposed sale of securities under Rule 144.SEC
2026-08-254Statement of changes in beneficial ownership of securities2026-08-25SEC
2026-08-10SCHEDULE 13G/ASEC
2026-07-2310-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-07-228-KCurrent report2026-07-22SEC
2026-06-304Statement of changes in beneficial ownership of securities2026-06-30SEC
2026-06-014Statement of changes in beneficial ownership of securities2026-06-01SEC
2026-06-018-KCurrent report2026-06-01SEC
2026-05-15SCHEDULE 13G/ASEC
2026-05-15SCHEDULE 13G/ASEC
2026-05-14SCHEDULE 13GSEC
2026-05-143Initial statement of beneficial ownership of securities2026-05-12SEC
2026-05-138-KCurrent report2026-05-13SEC
2026-05-068-KCurrent report2026-05-06SEC
2026-04-238-KCurrent report2026-04-22SEC
2026-04-224Statement of changes in beneficial ownership of securities2026-04-22SEC
2026-04-2210-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-04-218-KCurrent report2026-04-21SEC
2026-04-02ARSAnnual report to security holders. 2025-12-31SEC
2026-04-02DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-04-02DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-03-31SEC
2026-04-018-KCurrent report2026-04-01SEC
2026-03-26SCHEDULE 13G/ASEC
2026-03-058-KCurrent report2026-03-05SEC
2026-03-034Statement of changes in beneficial ownership of securities2026-03-01SEC
2026-03-034Statement of changes in beneficial ownership of securities2026-03-01SEC
2026-03-034Statement of changes in beneficial ownership of securities2026-03-01SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-0800118.40K1
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
CastleKnight Management LP9.50%
Apollo Management Holdings, L.P.8.42%
BlackRock, Inc.7.76%
Eversept Partners, LP5.58%
NOMURA HOLDINGS INC4.76%
VANGUARD CAPITAL MANAGEMENT LLC3.75%
WHITEBOX ADVISORS LLC2.65%
STATE STREET CORP2.17%
VANGUARD PORTFOLIO MANAGEMENT LLC2.14%
Saba Capital Management, L.P.2.05%

Funds

Fund% owned
BlackRock High Yield Portfolio8.39%
RBC BlueBay High Yield Bond Fund7.40%
Franklin Income Focus ETF5.68%
MFS High Income Fund5.30%
BlackRock Multi-Asset Income Portfolio5.01%
JNL/PPM America High Yield Bond Fund3.98%
JPMorgan High Yield Fund3.83%
FlexShares High Yield Value - Scored Bond Index Fund3.56%
Xtrackers USD High Yield Corporate Bond ETF3.38%
VANGUARD TOTAL STOCK MARKET INDEX FUND2.71%

OakChart. CYH. Cached 15 minutes.